Jiemiao Hu
6PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 06, 2025
Collagen-disrupting attIL12 TIL therapy boosts deep T cell infiltration via dual signaling activation and CCKAR reduction in sarcomas.Jiemiao Hu, Harjeet Singh, Yining Jin
|Jan 10, 2024
Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models.Jiemiao Hu, Alexander J Lazar, Davis Ingram
|Feb 09, 2023
FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells.Qingnan Zhao, Jiemiao Hu, Lingyuan Kong
|Jan 14, 2022
Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors.Jiemiao Hu, Qing Yang, Wendong Zhang
|Jun 10, 2021
WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression.Man Wu, Xueqing Xia, Jiemiao Hu
|Feb 11, 2021
Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme.Jiemiao Hu, Qingnan Zhao, Ling-Yuan Kong
Pageof 1
Frequent Collaborators
5 joint publications
Shulin Li
2 joint publications
Amy B Heimberger
2 joint publications
Natalie Wall Fowlkes
1 joint publications
Jian Wang
1 joint publications
Hongwei Du
1 joint publications
Qingnan Zhao
1 joint publications
Jing Wang
1 joint publications
David Masopust
1 joint publications
Harjeet Singh
1 joint publications
Wendong Zhang
